Your browser doesn't support javascript.
loading
Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
Wallace, Sarah J; Worrall, Linda; Rose, Tanya A; Alyahya, Reem S W; Babbitt, Edna; Beeke, Suzanne; de Beer, Carola; Bose, Arpita; Bowen, Audrey; Brady, Marian C; Breitenstein, Caterina; Bruehl, Stefanie; Bryant, Lucy; Cheng, Bonnie B Y; Cherney, Leora R; Conroy, Paul; Copland, David A; Croteau, Claire; Cruice, Madeline; Dipper, Lucy; Hilari, Katerina; Howe, Tami; Kelly, Helen; Kiran, Swathi; Laska, Ann-Charlotte; Marshall, Jane; Murray, Laura L; Patterson, Janet; Pearl, Gill; Quinting, Jana; Rochon, Elizabeth; Rose, Miranda L; Rubi-Fessen, Ilona; Sage, Karen; Simmons-Mackie, Nina; Visch-Brink, Evy; Volkmer, Anna; Webster, Janet; Whitworth, Anne; Dorze, Guylaine Le.
  • Wallace SJ; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Worrall L; Queensland Aphasia Research Centre, Brisbane, QLD, Australia.
  • Rose TA; Centre of Research Excellence in Aphasia Recovery and Rehabilitation, Australia.
  • Alyahya RSW; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Babbitt E; Queensland Aphasia Research Centre, Brisbane, QLD, Australia.
  • Beeke S; Centre of Research Excellence in Aphasia Recovery and Rehabilitation, Australia.
  • de Beer C; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Bose A; Queensland Aphasia Research Centre, Brisbane, QLD, Australia.
  • Bowen A; Communication and Swallowing Disorders Department, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Brady MC; School of Health and Psychological Sciences, City, University of London, London, UK.
  • Breitenstein C; Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Bruehl S; Deparment of Psychology and Language Sciences, University College London, London, UK.
  • Bryant L; Faculty of Linguistics and Literary Studies & Medical School OWL, University of Bielefeld, Bielefeld, Germany.
  • Cheng BBY; School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK.
  • Cherney LR; Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, UK.
  • Conroy P; Nursing, Midwifery and Allied Health Professionals Research Unit, Glasgow Caledonian University, Glasgow, UK.
  • Copland DA; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Croteau C; St. Mauritius Rehabilitation Centre, Meerbusch, Germany.
  • Cruice M; Medical Faculty, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Dipper L; Clinical and Cognitive Neurosciences, Department of Neurology, RWTH Aachen University, Germany.
  • Hilari K; University of Technology Sydney Graduate School of Health, Faculty of Health, Sydney, NSW, Australia.
  • Howe T; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Kelly H; Queensland Aphasia Research Centre, Brisbane, QLD, Australia.
  • Kiran S; Centre of Research Excellence in Aphasia Recovery and Rehabilitation, Australia.
  • Laska AC; Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Marshall J; Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, UK.
  • Murray LL; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • Patterson J; Queensland Aphasia Research Centre, Brisbane, QLD, Australia.
  • Pearl G; Centre of Research Excellence in Aphasia Recovery and Rehabilitation, Australia.
  • Quinting J; School of Speech-Language Pathology and Audiology, Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Rochon E; School of Health and Psychological Sciences, City, University of London, London, UK.
  • Rose ML; School of Health and Psychological Sciences, City, University of London, London, UK.
  • Rubi-Fessen I; School of Health and Psychological Sciences, City, University of London, London, UK.
  • Sage K; School of Audiology and Speech Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Simmons-Mackie N; School of Clinical Therapies, University College Cork, Cork, Ireland.
  • Visch-Brink E; Department of Speech, Language, and Hearing Sciences, Boston University, Boston, MA, USA.
  • Volkmer A; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Webster J; School of Health and Psychological Sciences, City, University of London, London, UK.
  • Whitworth A; School of Communication Sciences and Disorders, Western University, London, ON, Canada.
  • Dorze GL; Research Service, VA Northern California Health Care System, Martinez, CA, USA.
Int J Lang Commun Disord ; 58(4): 1017-1028, 2023.
Article en En | MEDLINE | ID: mdl-36583427
ABSTRACT

BACKGROUND:

Evidence-based recommendations for a core outcome set (COS; minimum set of outcomes) for aphasia treatment research have been developed (the Research Outcome Measurement in Aphasia-ROMA, COS). Five recommended core outcome constructs communication, language, quality of life, emotional well-being and patient-reported satisfaction/impact of treatment, were identified through three international consensus studies. Constructs were paired with outcome measurement instruments (OMIs) during an international consensus meeting (ROMA-1). Before the current study (ROMA-2), agreement had not been reached on OMIs for the constructs of communication or patient-reported satisfaction/impact of treatment.

AIM:

To establish consensus on a communication OMI for inclusion in the ROMA COS. METHODS & PROCEDURES Research methods were based on recommendations from the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. Participants with expertise in design and conduct of aphasia trials, measurement instrument development/testing and/or communication outcome measurement were recruited through an open call. Before the consensus meeting, participants agreed on a definition of communication, identified appropriate OMIs, extracted their measurement properties and established criteria for their quality assessment. During the consensus meeting they short-listed OMIs and participants without conflicts of interest voted on the two most highly ranked instruments. Consensus was defined a priori as agreement by ≥ 70% of participants. OUTCOMES &

RESULTS:

In total, 40 researchers from nine countries participated in ROMA-2 (including four facilitators and three-panel members who participated in pre-meeting activities only). A total of 20 OMIs were identified and evaluated. Eight short-listed communication measures were further evaluated for their measurement properties and ranked. Participants in the consensus meeting (n = 33) who did not have conflicts of interest (n = 29) voted on the top two ranked OMIs The Scenario Test (TST) and the Communication Activities of Daily Living-3 (CADL-3). TST received 72% (n = 21) of 'yes' votes and the CADL-3 received 28% (n = 8) of 'yes' votes. CONCLUSIONS & IMPLICATIONS Consensus was achieved that TST was the preferred communication OMI for inclusion in the ROMA COS. It is currently available in the original Dutch version and has been adapted into English, German and Greek. Further consideration must be given to the best way to measure communication in people with mild aphasia. Development of a patient-reported measure for satisfaction with/impact of treatment and multilingual versions of all OMIs of the COS is still required. Implementation of the ROMA COS would improve research outcome measurement and the quality, relevance, transparency, replicability and efficiency of aphasia treatment research. WHAT THIS PAPER ADDS What is already known on this subject International consensus has been reached on five core constructs to be routinely measured in aphasia treatment studies. International consensus has also been established for OMIs for the three constructs of language, quality of life and emotional well-being. Before this study, OMIs for the constructs of communication and patient-reported satisfaction/impact of treatment were not established. What this paper adds to existing knowledge We gained international consensus on an OMI for the construct of communication. TST is recommended for inclusion in the ROMA COS for routine use in aphasia treatment research. What are the potential or actual clinical implications of this work? The ROMA COS recommends OMIs for a minimum set of outcomes for adults with post-stroke aphasia within phases I-IV aphasia treatment research. Although not intended for clinical use, clinicians may employ the instruments of the ROMA COS, considering the quality of their measurement properties. The systematic inclusion of a measure of communication, such as TST, in clinical practice could ultimately support the implementation of research evidence and best practices.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Afasia / Calidad de Vida / Comunicación Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Afasia / Calidad de Vida / Comunicación Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article